VIM and breast cancer: Another publication in 2024 by Zhang et al. showed sensitivity and specificity values of 78% and 83%, respectively, for distinguishing patients with BC of urothelial origin from healthy volunteers using methylation analysis of TWIST1 and VIM gene promoters in the deposits of cells contained in urine [64].